Integrated Biopharma, Inc. INBP
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.68% | 96.76% | 115.93% | 108.37% | 115.56% |
| Total Receivables | -38.60% | -28.05% | -15.04% | -9.17% | 16.32% |
| Inventory | -2.35% | -19.43% | -24.43% | -6.73% | -16.74% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 21.35% | -12.62% | 38.19% | 1.85% | 24.48% |
| Total Current Assets | -7.38% | -3.08% | -1.84% | 7.16% | 4.97% |
|
|
|||||
| Total Current Assets | -7.38% | -3.08% | -1.84% | 7.16% | 4.97% |
| Net Property, Plant & Equipment | 75.59% | 71.43% | -26.05% | -23.92% | -25.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.58% | -12.49% | -22.07% | -25.54% | -27.23% |
| Total Assets | 1.75% | 3.95% | -8.24% | -2.46% | -4.98% |
|
|
|||||
| Total Accounts Payable | 41.16% | 18.55% | -23.65% | 1.34% | -9.68% |
| Total Accrued Expenses | 6.99% | -15.89% | -37.33% | -35.55% | -51.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 78.06% | 40.52% | -72.30% | -50.31% | -28.68% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 36.58% | 10.96% | -36.48% | -20.98% | -30.62% |
|
|
|||||
| Total Current Liabilities | 36.58% | 10.96% | -36.48% | -20.98% | -30.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 456.25% | 639.73% | -33.98% | -52.48% | -60.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 67.34% | 45.78% | -36.33% | -23.85% | -34.22% |
|
|
|||||
| Common Stock & APIC | 0.37% | 0.49% | 0.48% | 0.52% | 0.53% |
| Retained Earnings | -9.05% | -5.29% | -0.65% | 2.10% | 2.51% |
| Treasury Stock & Other | 0.00% | 0.00% | 1.01% | 0.00% | 0.00% |
| Total Common Equity | -13.04% | -6.87% | 0.21% | 4.80% | 5.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.04% | -6.87% | 0.21% | 4.80% | 5.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.04% | -6.87% | 0.21% | 4.80% | 5.61% |
|
|
|||||